TCL Archive Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research November 15, 1996
TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007
TCL Archive In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients September 9, 1977